Pilot scale production of the vaccine adjuvant Proteoliposome derived Cochleates (AFCo1) from Neisseria meningitidis serogroup B

The use of new adjuvants in vaccine formulations is a subject of current research. Only few parenteral adjuvants have been licensed. We have developed a mucosal and parenteral adjuvant known as AFCo1 (Adjuvant Finlay Cochleate 1, derived from proteoliposomes of N. meningitidis B) using a dialysis pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Zayas, Caridad, González, Domingo, Acevedo, Reinaldo, del Campo, Judith, Lastre, Miriam, González, Elizabeth, Romeu, Belkis, Cuello, Maribel, Balboa, Julio, Cabrera, Osmir, Guilherme, Luisa, Pérez, Oliver
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Proceedings
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3582446/
https://www.ncbi.nlm.nih.gov/pubmed/23458578
http://dx.doi.org/10.1186/1471-2172-14-S1-S4

Ejemplares similares

Ejemplares similares